モダリスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/29 | 1,679 | 1,802 | 1,662 | 1,779 | +140 | +8.5% | 759,000 |
2021/06/28 | 1,585 | 1,647 | 1,562 | 1,639 | +59 | +3.7% | 269,300 |
2021/06/25 | 1,600 | 1,601 | 1,533 | 1,580 | +14 | +0.9% | 242,800 |
2021/06/24 | 1,530 | 1,567 | 1,524 | 1,566 | +33 | +2.2% | 170,000 |
2021/06/23 | 1,521 | 1,534 | 1,502 | 1,533 | +14 | +0.9% | 104,200 |
2021/06/22 | 1,463 | 1,533 | 1,434 | 1,519 | +102 | +7.2% | 206,000 |
2021/06/21 | 1,434 | 1,449 | 1,403 | 1,417 | -65 | -4.4% | 195,000 |
2021/06/18 | 1,540 | 1,545 | 1,462 | 1,482 | -42 | -2.8% | 263,100 |
2021/06/17 | 1,492 | 1,532 | 1,456 | 1,524 | +19 | +1.3% | 235,600 |
2021/06/16 | 1,498 | 1,518 | 1,460 | 1,505 | -8 | -0.5% | 206,900 |
2021/06/15 | 1,450 | 1,540 | 1,448 | 1,513 | +81 | +5.7% | 426,000 |
2021/06/14 | 1,421 | 1,440 | 1,402 | 1,432 | +41 | +2.9% | 157,100 |
2021/06/11 | 1,442 | 1,462 | 1,363 | 1,391 | -32 | -2.2% | 291,200 |
2021/06/10 | 1,469 | 1,529 | 1,411 | 1,423 | -27 | -1.9% | 362,700 |
2021/06/09 | 1,548 | 1,565 | 1,433 | 1,450 | -76 | -5% | 636,800 |
2021/06/08 | 1,406 | 1,550 | 1,405 | 1,526 | +149 | +10.8% | 827,900 |
2021/06/07 | 1,304 | 1,386 | 1,304 | 1,377 | +75 | +5.8% | 184,900 |
2021/06/04 | 1,301 | 1,335 | 1,290 | 1,302 | -24 | -1.8% | 158,500 |
2021/06/03 | 1,369 | 1,369 | 1,318 | 1,326 | -44 | -3.2% | 191,000 |
2021/06/02 | 1,395 | 1,405 | 1,358 | 1,370 | -1 | -0.1% | 125,700 |
2021/06/01 | 1,362 | 1,379 | 1,340 | 1,371 | +9 | +0.7% | 155,100 |
2021/05/31 | 1,412 | 1,412 | 1,359 | 1,362 | -51 | -3.6% | 174,900 |
2021/05/28 | 1,433 | 1,439 | 1,400 | 1,413 | -42 | -2.9% | 182,400 |
2021/05/27 | 1,421 | 1,455 | 1,389 | 1,455 | +34 | +2.4% | 216,100 |
2021/05/26 | 1,435 | 1,452 | 1,405 | 1,421 | -15 | -1% | 130,300 |
2021/05/25 | 1,402 | 1,436 | 1,396 | 1,436 | +27 | +1.9% | 140,500 |
2021/05/24 | 1,400 | 1,425 | 1,371 | 1,409 | -18 | -1.3% | 243,800 |
2021/05/21 | 1,383 | 1,456 | 1,360 | 1,427 | +59 | +4.3% | 316,600 |
2021/05/20 | 1,317 | 1,383 | 1,314 | 1,368 | +24 | +1.8% | 282,200 |
2021/05/19 | 1,296 | 1,407 | 1,295 | 1,344 | +20 | +1.5% | 498,900 |
2021/05/18 | 1,170 | 1,326 | 1,118 | 1,324 | -73 | -5.2% | 1,626,500 |
2021/05/17 | 1,468 | 1,468 | 1,392 | 1,397 | -71 | -4.8% | 316,700 |
2021/05/14 | 1,426 | 1,468 | 1,396 | 1,468 | +42 | +2.9% | 254,500 |
2021/05/13 | 1,473 | 1,475 | 1,420 | 1,426 | -48 | -3.3% | 306,500 |
2021/05/12 | 1,500 | 1,561 | 1,465 | 1,474 | -43 | -2.8% | 385,000 |
2021/05/11 | 1,549 | 1,553 | 1,495 | 1,517 | -55 | -3.5% | 534,700 |
2021/05/10 | 1,690 | 1,690 | 1,572 | 1,572 | -134 | -7.9% | 728,000 |
2021/05/07 | 1,653 | 1,736 | 1,632 | 1,706 | -2 | -0.1% | 510,300 |
2021/05/06 | 1,785 | 1,787 | 1,694 | 1,708 | -76 | -4.3% | 449,200 |
2021/04/30 | 1,804 | 1,806 | 1,763 | 1,784 | -36 | -2% | 235,000 |
2021/04/28 | 1,884 | 1,884 | 1,813 | 1,820 | -70 | -3.7% | 167,200 |
2021/04/27 | 1,927 | 1,929 | 1,883 | 1,890 | -30 | -1.6% | 126,700 |
2021/04/26 | 1,873 | 1,924 | 1,843 | 1,920 | +42 | +2.2% | 185,100 |
2021/04/23 | 1,891 | 1,926 | 1,864 | 1,878 | -49 | -2.5% | 113,800 |
2021/04/22 | 1,895 | 1,927 | 1,895 | 1,927 | +63 | +3.4% | 97,500 |
2021/04/21 | 1,912 | 1,937 | 1,856 | 1,864 | -84 | -4.3% | 217,500 |
2021/04/20 | 1,940 | 1,976 | 1,922 | 1,948 | -5 | -0.3% | 163,400 |
2021/04/19 | 1,996 | 2,005 | 1,951 | 1,953 | -59 | -2.9% | 231,800 |
2021/04/16 | 2,015 | 2,030 | 1,994 | 2,012 | +19 | +1% | 101,600 |
2021/04/15 | 1,996 | 2,017 | 1,984 | 1,993 | +6 | +0.3% | 122,100 |
1001~
1050
件表示中 / 1223件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
モダリス | 9,200円 | - | - | 0.00% | - | 2.01倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
ノイルイミューン | 17,500円 | -28.6% | - | 0.00% | - | 1.61倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
ティムス | 16,500円 | - | - | 0.00% | - | 2.68倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国CORXEL社に導出 |
PRISMBio | 18,600円 | +14.8% | - | 0.00% | - | 2.23倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
ブライトパス | 6,800円 | -100.0% | - | 0.00% | - | 7.51倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入iPS由来細胞医薬や抗体医薬開発に注力 |
市場注目の銘柄
チャート関連のコラム